Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008605 · ClinicalTrials.gov registry record · Phase 3
Caverject User Study
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 48
- Enrollment target
NCT01008605 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 48 participants.
The verdict
NCT01008605, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the usability of the system.
Interventions
- OTHER delivery system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01008605
The ClinicalTrials.gov registry entry for NCT01008605 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which delivery system is the first listed.
NCT01008605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01008605 about?
NCT01008605 is a clinical study titled "Caverject User Study". The purpose of this study is to demonstrate the usability of the system.
What is the current status of trial NCT01008605?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 48 participants. The study started on 2011-02. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01008605?
The interventions under investigation include: delivery system (OTHER).
Who is sponsoring clinical trial NCT01008605?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.